637 results Stibbe advises Mylan Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda. Stibbe represents Maersk Stibbe assisted Maersk in an investigation by the European Commission in the container line shipping sector. Stibbe advises Sonova Holding AG Stibbe has advised Sonova Holding AG on its acquisition of AudioNova B.V. from HAL Investments. The value of AudioNova is EUR 830 million. Stibbe advises BC Partners and CPPIB Stibbe advises BC Partners and Canada Pension Plan Investment Board (CPPIB) on their 30% stake alongside Altice N.V. in Suddenlink and Cablevision. Stibbe advises AkzoNobel Stibbe advises AkzoNobel in two applications for annulment brought by AkzoNobel in relation to the European Commission's decision in the heat stabilisers cartel. Stibbe advises on the IPO of ABN AMRO Stibbe advises ABN AMRO, Deutsche Bank and Morgan Stanley (as joint global coordinators) and the other underwriters on the IPO of ABN AMRO. Stibbe advises Hearthside Group Holdings in acquisition of VSI Stibbe advises Hearthside Group Holdings LLC in the acquisition of VSI (B.V. Vurense Snack Industrie) from NPM Capital. Besides the majority stake of NPM Capital Hearthside also acquired the remaining shares. Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition Stibbe advises Tribune Media Company Advising Tribune Media Company and its subsidiary Gracenote, the world’s leading provider of entertainment data, on its acquisition of Infostrada Sports. Stibbe advises Vodafone Stibbe advises Vodafone Netherlands with the filing of a lawsuit with the Court of Rotterdam against the ACM in respect of its approval of KPN’s takeover of FTTH operator Reggefiber. Stibbe advises Akzo Nobel Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents. Stibbe advises Credit Suisse Stibbe advised Credit Suisse on the imposement of a fine by the European Commission for participating in a cartel involving interest rate products denominated in Swiss francs. Stibbe advises Plantum Stibbe advises Plantum (in its capacity as the Dutch association for the plant reproduction material sector) on the establishment of an International Licensing Platform (ILP) Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business. Stibbe advises Pilkington Successfully defended Pilkington in proceedings against an ACM decision to impose a fine for alleged participation in a cartel in the double-glass sector. Stibbe advises Aalberts Industries Successfully defended Aalberts Industries in a Commission appeal against a General Court judgment that had struck down a EUR 100+ million fine imposed on Aalberts. Stibbe advises Mars Representing Mars in legal proceedings before the District Court against Nestlé on allegations of abuse of dominance in the chocolate market. Stibbe advises AkzoNobel Assisting AkzoNobel in proceedings before the EU General Court concerning the European Commission's attempt to re-publish an extended non-confidential version of the hydrogen peroxide cartel decision (that includes leniency information). Pagination Previous page Page 33 Current page 34 Page 35 Page 36 Next page
Stibbe advises Mylan Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda.
Stibbe represents Maersk Stibbe assisted Maersk in an investigation by the European Commission in the container line shipping sector.
Stibbe advises Sonova Holding AG Stibbe has advised Sonova Holding AG on its acquisition of AudioNova B.V. from HAL Investments. The value of AudioNova is EUR 830 million.
Stibbe advises BC Partners and CPPIB Stibbe advises BC Partners and Canada Pension Plan Investment Board (CPPIB) on their 30% stake alongside Altice N.V. in Suddenlink and Cablevision.
Stibbe advises AkzoNobel Stibbe advises AkzoNobel in two applications for annulment brought by AkzoNobel in relation to the European Commission's decision in the heat stabilisers cartel.
Stibbe advises on the IPO of ABN AMRO Stibbe advises ABN AMRO, Deutsche Bank and Morgan Stanley (as joint global coordinators) and the other underwriters on the IPO of ABN AMRO.
Stibbe advises Hearthside Group Holdings in acquisition of VSI Stibbe advises Hearthside Group Holdings LLC in the acquisition of VSI (B.V. Vurense Snack Industrie) from NPM Capital. Besides the majority stake of NPM Capital Hearthside also acquired the remaining shares.
Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition
Stibbe advises Tribune Media Company Advising Tribune Media Company and its subsidiary Gracenote, the world’s leading provider of entertainment data, on its acquisition of Infostrada Sports.
Stibbe advises Vodafone Stibbe advises Vodafone Netherlands with the filing of a lawsuit with the Court of Rotterdam against the ACM in respect of its approval of KPN’s takeover of FTTH operator Reggefiber.
Stibbe advises Akzo Nobel Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents.
Stibbe advises Credit Suisse Stibbe advised Credit Suisse on the imposement of a fine by the European Commission for participating in a cartel involving interest rate products denominated in Swiss francs.
Stibbe advises Plantum Stibbe advises Plantum (in its capacity as the Dutch association for the plant reproduction material sector) on the establishment of an International Licensing Platform (ILP)
Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.
Stibbe advises Pilkington Successfully defended Pilkington in proceedings against an ACM decision to impose a fine for alleged participation in a cartel in the double-glass sector.
Stibbe advises Aalberts Industries Successfully defended Aalberts Industries in a Commission appeal against a General Court judgment that had struck down a EUR 100+ million fine imposed on Aalberts.
Stibbe advises Mars Representing Mars in legal proceedings before the District Court against Nestlé on allegations of abuse of dominance in the chocolate market.
Stibbe advises AkzoNobel Assisting AkzoNobel in proceedings before the EU General Court concerning the European Commission's attempt to re-publish an extended non-confidential version of the hydrogen peroxide cartel decision (that includes leniency information).